Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10900332 | Cancer Letters | 2005 | 6 Pages |
Abstract
In this study, we focus on the potential interaction of pp32/I-1PP2A (pp32) with the Raf-MEK-ERK signaling pathway. We show that overexpressed pp32 suppresses Raf-1 activation, thereby downregulating the level of ERK activation. This suppression of Raf-1 requires the C-terminal half of pp32. Conversely, knock-down of PP32 by siRNA enhances ERK and MEK activations. Taken together, we propose that tumor-suppression by pp32 is, at least in part, mediated by downregulation of the Raf-MEK-ERK signaling pathway.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Chikako Fukukawa, Nobuhiro Tanuma, Tadashi Okada, Kunimi Kikuchi, Hiroshi Shima,